Sensus Healthcare (SRTS) Competitors $3.15 -0.03 (-0.94%) Closing price 04:00 PM EasternExtended Trading$3.14 -0.02 (-0.48%) As of 05:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SRTS vs. INFU, CVRX, ELMD, NYXH, SGHT, KRMD, CV, MBOT, AVR, and LUCDShould you be buying Sensus Healthcare stock or one of its competitors? The main competitors of Sensus Healthcare include InfuSystem (INFU), CVRx (CVRX), Electromed (ELMD), Nyxoah (NYXH), Sight Sciences (SGHT), KORU Medical Systems (KRMD), CapsoVision (CV), Microbot Medical (MBOT), Anteris Technologies Global (AVR), and Lucid Diagnostics (LUCD). These companies are all part of the "medical equipment" industry. Sensus Healthcare vs. Its Competitors InfuSystem CVRx Electromed Nyxoah Sight Sciences KORU Medical Systems CapsoVision Microbot Medical Anteris Technologies Global Lucid Diagnostics InfuSystem (NYSE:INFU) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, profitability, earnings, media sentiment, analyst recommendations and risk. Does the media prefer INFU or SRTS? In the previous week, Sensus Healthcare had 2 more articles in the media than InfuSystem. MarketBeat recorded 3 mentions for Sensus Healthcare and 1 mentions for InfuSystem. InfuSystem's average media sentiment score of 1.61 beat Sensus Healthcare's score of 0.38 indicating that InfuSystem is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InfuSystem 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Sensus Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger earnings and valuation, INFU or SRTS? Sensus Healthcare has lower revenue, but higher earnings than InfuSystem. Sensus Healthcare is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInfuSystem$139.89M1.48$870K$0.2344.17Sensus Healthcare$41.81M1.24$6.65M-$0.06-52.50 Which has more risk & volatility, INFU or SRTS? InfuSystem has a beta of 1.82, indicating that its stock price is 82% more volatile than the S&P 500. Comparatively, Sensus Healthcare has a beta of 1.41, indicating that its stock price is 41% more volatile than the S&P 500. Do insiders & institutionals have more ownership in INFU or SRTS? 71.1% of InfuSystem shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 11.4% of InfuSystem shares are owned by company insiders. Comparatively, 8.9% of Sensus Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Do analysts prefer INFU or SRTS? InfuSystem currently has a consensus price target of $12.50, suggesting a potential upside of 23.03%. Sensus Healthcare has a consensus price target of $8.00, suggesting a potential upside of 153.97%. Given Sensus Healthcare's higher probable upside, analysts clearly believe Sensus Healthcare is more favorable than InfuSystem.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InfuSystem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 3 Strong Buy rating(s) 4.00Sensus Healthcare 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is INFU or SRTS more profitable? InfuSystem has a net margin of 1.12% compared to Sensus Healthcare's net margin of -2.26%. InfuSystem's return on equity of 2.78% beat Sensus Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets InfuSystem1.12% 2.78% 1.41% Sensus Healthcare -2.26%-1.58%-1.41% SummaryInfuSystem beats Sensus Healthcare on 13 of the 17 factors compared between the two stocks. Get Sensus Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for SRTS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRTS vs. The Competition Export to ExcelMetricSensus HealthcareMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$51.79M$6.69B$5.75B$10.28BDividend YieldN/A1.20%5.72%4.60%P/E Ratio-52.5025.8474.9926.41Price / Sales1.24173.23456.1088.49Price / Cash7.3622.1825.8129.91Price / Book0.924.9413.256.28Net Income$6.65M$176.38M$3.29B$270.38M7 Day Performance-2.48%4.96%0.46%2.69%1 Month Performance-5.97%6.43%4.59%5.98%1 Year Performance-48.28%10.59%73.41%25.93% Sensus Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRTSSensus Healthcare2.6564 of 5 stars$3.15-0.9%$8.00+154.0%-47.8%$51.79M$41.81M-52.5040INFUInfuSystem3.1357 of 5 stars$10.26+1.0%$12.50+21.8%+53.5%$209.57M$139.89M171.03410Positive NewsCVRXCVRx2.7248 of 5 stars$7.95+1.7%$14.00+76.1%+0.3%$204.51M$51.29M-3.79160News CoveragePositive NewsELMDElectromed3.9972 of 5 stars$24.96+2.0%$36.25+45.2%+31.0%$204.31M$64M33.28160News CoverageInsider TradeNYXHNyxoah3.1773 of 5 stars$5.84-1.5%$15.00+156.8%-33.2%$201.98M$4.89M-2.54110SGHTSight Sciences3.5815 of 5 stars$3.69flat$4.42+19.7%-50.2%$193.24M$79.87M-3.84210News CoverageAnalyst UpgradeKRMDKORU Medical Systems2.7141 of 5 stars$4.08+0.5%$4.63+13.4%+56.8%$187.71M$33.65M-45.3380Positive NewsCVCapsoVisionN/A$3.64+1.7%$5.50+51.1%N/A$167.45MN/A0.0090MBOTMicrobot Medical2.3506 of 5 stars$4.50+23.0%$9.00+100.0%+309.1%$166.70MN/A-7.7620Analyst UpgradeGap DownHigh Trading VolumeAVRAnteris Technologies Global1.718 of 5 stars$4.64+11.5%$16.50+255.6%N/A$150.02M$2.48M0.00138Positive NewsHigh Trading VolumeLUCDLucid Diagnostics3.184 of 5 stars$1.23-10.2%$3.65+196.7%+21.7%$148.61M$4.35M-1.0370Gap UpHigh Trading Volume Related Companies and Tools Related Companies INFU Alternatives CVRX Alternatives ELMD Alternatives NYXH Alternatives SGHT Alternatives KRMD Alternatives CV Alternatives MBOT Alternatives AVR Alternatives LUCD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SRTS) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sensus Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sensus Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SRTS Stock Alerts